ADC Therapeutics S.A. (ADCT) quarterly cash flow statement — complete operating, investing & financing history
ADC Therapeutics S.A. (ADCT) cash flow statement — 9-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -11.81M | -29.71M | -31.12M | -29.63M | -24.09M | -56.33M | -21.85M | -25.04M | -32.84M | -44.09M | -31.63M | -36.67M | -34.99M | -15.39M | -52.1M | 2.19M | -53.01M | -33.88M | -61.63M | -58.59M |
| Operating CF Margin % | -61.34% | -148.31% | -134.98% | -180.37% | -127.86% | -244.58% | -129.23% | -135.63% | -188.66% | -244.25% | -188.4% | -253.04% | -181.44% | -81.04% | -74.64% | 2.88% | -306.58% | -72.87% | -362.32% | -445.64% |
| Operating CF Growth % | 50.98% | 47.26% | -42.43% | -18.32% | 26.66% | -27.76% | 30.92% | 31.71% | 6.13% | -186.48% | 39.28% | -1770.75% | 34% | 54.57% | 15.47% | 103.75% | 8.62% | 38.56% | -19.22% | -32.29% |
| Net Income | -16.57M | -32.97M | -6.41M | -40.97M | -56.65M | -38.6M | -30.73M | -43.97M | -36.54M | -46.61M | -85.03M | -46.73M | -48.92M | -59.37M | -24.16M | -50.61M | -64.37M | -16.66M | -34.38M | -71.55M |
| Depreciation & Amortization | 1.05M | 114K | 113K | 122K | 1.18M | 801K | 793K | 802K | 838K | 843K | 1.54M | 885K | 812K | 723K | 576K | 572K | 586K | 594K | 759K | 658K |
| Stock-Based Compensation | 4.55M | 2.44M | 6.13M | 2M | 1.81M | 2.42M | 1.62M | 2.81M | 1.99M | 158K | 2.22M | 2.08M | 1.12M | 8.07M | 7.54M | 14.56M | 13.82M | 13.4M | 13.46M | 14.8M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -578K | -5.1M | -69K | 6.84M | 441K | -4.13M | -3.86M | -21.97M | 0 |
| Other Non-Cash Items | -11.78M | 5.71M | -19.09M | 8.82M | 14.22M | 8.56M | -3.56M | 6.78M | 5.69M | 11.43M | 49.41M | 8.13M | 12.09M | 2.34M | 383K | 41.88M | -15.38M | -25.81M | -9.92M | 11.21M |
| Working Capital Changes | 10.93M | -5M | -11.87M | 392K | 15.35M | -29.52M | 10.03M | 8.54M | -4.82M | -9.92M | 231K | -463K | 5.02M | 32.91M | -43.28M | -4.65M | 16.47M | -1.55M | -9.58M | -13.7M |
| Change in Receivables | 3.01M | -1.93M | -6.4M | 3.27M | 5.58M | -11.45M | 3.71M | -1.26M | 319K | 2M | -4M | 2.7M | 188K | 48.9M | -49.69M | -2.42M | 5.89M | 3.47M | -14.32M | -13.82M |
| Change in Inventory | -3.29M | 16K | -868.24K | -516K | -706K | -306K | -2.8M | -880K | 518K | -568K | 167K | -3.48M | -2.05M | -348K | -2.82M | -1.86M | -3.93M | -355K | -2.06M | 7K |
| Change in Payables | 7.47M | -3.87M | 1.09M | -1.29M | -6.22M | -2.46M | 3.68M | 4.87M | -4.84M | -1.25M | 0 | -2.71M | 2.98M | -3.66M | 721K | -1.38M | -3.41M | 4.38M | 1.74M | -3.93M |
| Cash from Investing | 142 | -32K | 687.91K | -2.19K | 0 | -264K | -90K | -216K | -30K | -531K | -327K | -661K | -1.21M | -1.02M | -117K | -254K | -689K | -1.45M | -830K | -2.34M |
| Capital Expenditures | 142 | -32K | -11.57K | -2.19K | 0 | -264K | -90K | -216K | -30K | -531K | -327K | -661K | -1.21M | -1.02M | -104K | -194K | -50K | -229K | -420K | -1.41M |
| CapEx % of Revenue | 0% | 0.16% | 0.05% | 0.01% | - | 1.15% | 0.53% | 1.17% | 0.17% | 2.94% | 1.95% | 4.56% | 6.29% | 5.35% | 0.15% | 0.25% | 0.29% | 0.49% | 2.47% | 10.69% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 699.49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13K | -60K | -639K | -1.22M | -410K | -933K |
| Cash from Financing | -99K | -583K | 58.21M | -198K | 93.78M | 271K | -1.12M | -879K | 98.7M | 356K | -1K | 349K | 73.1M | 425K | -2.45M | 2.37M | -252K | -258K | -1.22M | 219.3M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -409K | -261K | -196K | -1.93M | 114.24M | -252K | -258K | -231K | -229K |
| Equity Issued (Net) | 118K | 185K | 59.52M | -479K | 50.79M | 0 | 43K | -1.23M | 0 | 0 | -1K | 0 | 0 | 0 | -283K | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -20K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -217K | -768K | -1.31M | 281K | 42.99M | 271K | -1.16M | 346K | 98.7M | 356K | 0 | 758K | 73.36M | 621K | -234K | -111.88M | 0 | 0 | -987K | 219.53M |
| Net Change in Cash | -11.91M | -30.33M | 26.6M | -29.82M | 69.86M | -56.17M | -23.41M | -25.85M | 65.83M | -44.31M | -31.81M | -37.1M | 36.96M | -15.89M | -54.42M | 4.08M | -54.1M | -35.67M | -63.65M | 158.31M |
| Free Cash Flow | -11.81M | -29.74M | -31.13M | -29.63M | -24.09M | -56.6M | -21.94M | -25.26M | -32.88M | -44.63M | -31.96M | -37.33M | -36.2M | -16.41M | -52.21M | 1.94M | -53.82M | -35M | -62.16M | -60.93M |
| FCF Margin % | -61.34% | -148.47% | -135.03% | -180.37% | -127.86% | -245.73% | -129.76% | -136.8% | -188.83% | -247.19% | -190.35% | -257.6% | -187.73% | -86.39% | -74.81% | 2.54% | -311.25% | -75.27% | -365.46% | -463.42% |
| FCF Growth % | 50.98% | 47.45% | -41.89% | -17.3% | 26.73% | -26.83% | 31.35% | 32.34% | 9.19% | -171.98% | 38.79% | -2023.44% | 32.74% | 53.12% | 16.01% | 103.19% | 8.72% | 37.28% | -18.48% | -33.36% |
| FCF per Share | -0.08 | -0.19 | -0.21 | -0.22 | -0.21 | -0.53 | -0.21 | -0.24 | -0.34 | -0.54 | -0.39 | -0.45 | -0.44 | -0.20 | -0.65 | 0.02 | -0.70 | -0.46 | -0.81 | -0.79 |
| FCF Conversion (FCF/Net Income) | 0.71x | 0.90x | 4.86x | 0.72x | 0.43x | 1.46x | 0.71x | 0.57x | 0.90x | 0.95x | 0.37x | 0.77x | 0.72x | 0.26x | 2.16x | -0.04x | 0.82x | 2.03x | 1.79x | 0.82x |
| Interest Paid | -3.4M | 0 | 0 | 3.66M | 3.62M | 2.05M | 3.76M | 4.07M | 3.49M | 4.38M | 3.96M | 3.91M | 4.73M | 2.79M | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |